Dear Pathists, as things seem to gather pace in our open data campaign, the BMJ has put its considerable weight behind holding Roche accountable for its unfulfilled promise made 3 years ago of making full clinical study reports available to us and anyone else who logged into their website. The saga has been instrumental in defining some of the problems with current reporting models of clainical trials. Below is the list of goodies from the campaign. Please disseminate.
Best wishes,
Tom.
Tamiflu open data campaign
http://www.bmj.com/tamiflu
Also:
Editorial
Godlee F. Clinical trial data for all
drugs in current use. BMJ 2012;345:e7304 doi:
10.1136/bmj.e7304 (Published 29 October 2012)
http://www.bmj.com/content/345/bmj.e7304
Feature
Payne
D. Tamiflu:
the battle for secret drug data. BMJ 2012;345:e7303 doi: 10.1136/bmj.e7303 (Published 29
October 2012)
http://www.bmj.com/content/345/bmj.e7303
News
Zosia
Kmietowicz. Academics plea for politicians to tackle problem of missing data. BMJ 2012;345:e7306 doi: 10.1136/bmj.e7306
(Published 29 October 2012)
http://www.bmj.com/content/345/bmj.e7306
Correspondence
Godlee F. Open letter to Roche about
oseltamivir trial dataBMJ 2012;345:e7305 doi:
10.1136/bmj.e7305 (Published 29 October 2012). http://www.bmj.com/content/345/bmj.e7305
Podcast (click on the fish icon right hand side, upper corner of webpage) http://www.bmj.com/multimedia